Cadrenal Therapeutics Inc. Common Stock (CVKD) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Cadrenal Therapeutics Inc...

NASDAQ: CVKD · Real-Time Price · USD
13.25
0.74 (5.92%)
At close: Sep 05, 2025, 3:59 PM
13.01
-1.83%
After-hours: Sep 05, 2025, 05:16 PM EDT

Cadrenal Therapeutics Common Stock Revenue

Cadrenal Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Cadrenal Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
4
Market Cap
27.12M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 n/a
Dec 31, 2023 0 n/a
Dec 31, 2022 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.